Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.
Rafaeva M, Jensen ARD, Horton ER, Zornhagen KW, Strøbech JE, Fleischhauer L, Mayorca-Guiliani AE, Nielsen SR, Grønseth DS, Kuś F, Schoof EM, Arnes L, Koch M, Clausen-Schaumann H, Izzi V, Reuten R, Erler JT.
Rafaeva M, et al. Among authors: erler jt.
Front Immunol. 2023 Jul 18;14:1154528. doi: 10.3389/fimmu.2023.1154528. eCollection 2023.
Front Immunol. 2023.
PMID: 37539058
Free PMC article.